Fischman D L, Leon M B, Baim D S, Schatz R A, Savage M P, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M
Jefferson Medical College, Philadelphia, Division of Cardiology, PA 19107.
N Engl J Med. 1994 Aug 25;331(8):496-501. doi: 10.1056/NEJM199408253310802.
Coronary-stent placement is a new technique in which a balloon-expandable, stainless-steel, slotted tube is implanted at the site of a coronary stenosis. The purpose of this study was to compare the effects of stent placement and standard balloon angioplasty on angiographically detected restenosis and clinical outcomes.
We randomly assigned 410 patients with symptomatic coronary disease to elective placement of a Palmaz-Schatz stent or to standard balloon angioplasty. Coronary angiography was performed at base line, immediately after the procedure, and six months later.
The patients who underwent stenting had a higher rate of procedural success than those who underwent standard balloon angioplasty (96.1 percent vs. 89.6 percent, P = 0.011), a larger immediate increase in the diameter of the lumen (1.72 +/- 0.46 vs. 1.23 +/- 0.48 mm, P < 0.001), and a larger luminal diameter immediately after the procedure (2.49 +/- 0.43 vs. 1.99 +/- 0.47 mm, P < 0.001). At six months, the patients with stented lesions continued to have a larger luminal diameter (1.74 +/- 0.60 vs. 1.56 +/- 0.65 mm, P = 0.007) and a lower rate of restenosis (31.6 percent vs. 42.1 percent, P = 0.046) than those treated with balloon angioplasty. There were no coronary events (death; myocardial infarction; coronary-artery bypass surgery; vessel closure, including stent thrombosis; or repeated angioplasty) in 80.5 percent of the patients in the stent group and 76.2 percent of those in the angioplasty group (P = 0.16). Revascularization of the original target lesion because of recurrent myocardial ischemia was performed less frequently in the stent group than in the angioplasty group (10.2 percent vs. 15.4 percent, P = 0.06).
In selected patients, placement of an intracoronary stent, as compared with balloon angioplasty, results in an improved rate of procedural success, a lower rate of angiographically detected restenosis, a similar rate of clinical events after six months, and a less frequent need for revascularization of the original coronary lesion.
冠状动脉支架置入术是一种新技术,即将球囊可扩张的不锈钢开槽管植入冠状动脉狭窄部位。本研究的目的是比较支架置入术与标准球囊血管成形术对血管造影检测到的再狭窄及临床结局的影响。
我们将410例有症状的冠心病患者随机分配至择期置入Palmaz-Schatz支架或接受标准球囊血管成形术。在基线、术后即刻及6个月后进行冠状动脉造影。
接受支架置入术的患者手术成功率高于接受标准球囊血管成形术的患者(96.1%对89.6%,P = 0.011),术后管腔直径即刻增加更大(1.72±0.46对1.23±0.48 mm,P<0.001),且术后即刻管腔直径更大(2.49±0.43对1.99±0.47 mm,P<0.001)。6个月时,置入支架病变的患者与接受球囊血管成形术治疗的患者相比,仍有更大的管腔直径(1.74±0.60对1.56±0.65 mm,P = 0.007)和更低的再狭窄率(31.6%对42.1%,P = 0.046)。支架组80.5%的患者和血管成形术组76.2%的患者未发生冠状动脉事件(死亡、心肌梗死、冠状动脉旁路移植术、血管闭塞,包括支架血栓形成或重复血管成形术)(P = 0.16)。因复发性心肌缺血对原靶病变进行血运重建在支架组比血管成形术组更少(10.2%对15.4%,P = 0.06)。
在选定患者中,与球囊血管成形术相比,冠状动脉内支架置入术可提高手术成功率,降低血管造影检测到的再狭窄率,6个月后临床事件发生率相似,且对原冠状动脉病变进行血运重建的需求更少。